# OZEM holdings: all 24 positions

> All 24 OZEM holdings with weights, as of Oct 14, 2026. The top 3 are LLY 14.21%, NVO 11.96% and PFE 8.44%. Download the full list as a CSV.

Data as of Oct 14, 2026. Rebuilt every trading night.

OZEM held 24 positions as of Oct 14, 2026. Eli Lilly & Co is the largest at 14.21%; the top 10 are 67.9% of the fund.

Source: Roundhill (https://www.roundhillinvestments.com/assets/data/filepointroundhill.40ru.ru_holdings_10142026.csv).

| # | Holding | Ticker | Weight |
| --- | --- | --- | --- |
| 1 | Eli Lilly & Co | LLY | 14.21% |
| 2 | Novo Nordisk A/S | NVO | 11.96% |
| 3 | Pfizer Inc | PFE | 8.44% |
| 4 | CSPC Pharmaceutical Group Ltd |  | 6.11% |
| 5 | Kailera Therapeutics Inc | KLRA | 5.21% |
| 6 | Chugai Pharmaceutical Co Ltd |  | 4.77% |
| 7 | Amgen Inc | AMGN | 4.73% |
| 8 | Viking Therapeutics Inc | VKTX | 4.58% |
| 9 | AstraZeneca PLC | AZN | 4.07% |
| 10 | Hanmi Pharm Co Ltd |  | 3.80% |
| 11 | Roche Holding AG |  | 3.52% |
| 12 | Zealand Pharma A/S |  | 3.47% |
| 13 | Ascletis Pharma Inc |  | 3.31% |
| 14 | Jiangsu Hengrui Pharmaceuticals Co Ltd |  | 2.88% |
| 15 | United Laboratories International Holdings Ltd/The |  | 2.85% |
| 16 | Hansoh Pharmaceutical Group Co Ltd |  | 2.64% |
| 17 | Innovent Biologics Inc |  | 2.38% |
| 18 | Gubra A/S |  | 2.20% |
| 19 | Gilead Sciences Inc | GILD | 2.03% |
| 20 | MBX Biosciences Inc | MBX | 1.86% |
| 21 | Structure Therapeutics Inc | GPCR | 1.85% |
| 22 | Rhythm Pharmaceuticals Inc | RYTM | 1.43% |
| 23 | Shionogi & Co Ltd |  | 1.36% |
| 24 | Wave Life Sciences Inc | WVE | 0.26% |
| | First American Government Obligations Fund 12/01/2031 | | 0.35% |
| | Swiss Franc | | −0.48% |
| | Cash and other net assets | | 0.21% |

The largest 24 of 24 positions are shown. All of them: https://etfiq.com/funds/ozem/holdings/ozem-holdings.csv (CSV) or https://etfiq.com/data/books/ozem.json (JSON).

Fund page: https://etfiq.com/funds/ozem

Cite: ETFIQ, Holdings of OZEM, data as of Oct 14, 2026. https://etfiq.com/funds/ozem/holdings/